The Diagnostic and Clinical Significance of TFE3 Immunohistochemical Nuclear Expression in Solitary Fibrous Tumour

Abstract

TFE3表达在孤立性纤维性肿瘤（SFTS）及其组织学模拟物（转录因子E3）进行了调查，并诊断价值和SFTS TFE3核表达的临床意义进行了探讨。在50例SFTS那是手术切除执行对TFE3免疫组化分析。对照是来自恶性外周神经鞘瘤，滑膜肉瘤，去分化脂肪肉瘤，梭形细胞脂肪瘤，和隆突性皮肤样品的组织。患者TFE3阳性和TFE3阴性表达存活率通过Kaplan-Meier分析评估。在50（88％）44 SFTS中，检测用于TFE3核免疫反应性。所述TFE3表达滑膜肉瘤，恶性周围神经鞘瘤，隆突性皮肤，和梭形细胞脂肪瘤和弱阳性的所有样品中阴性2 10的情况下，去分化脂肪肉瘤的。荧光原位杂交（FISH）证实，TFE3蛋白的表达不会被基因易位引起。还有就是TFE3表达和SFT患者的预后的相关性差异无统计学意义。因此，TFE3能够增强SFTS及其组织学模拟物的鉴别诊断，并且可以潜在地用作诊断标记物。调查结果还提供了有价值的见解SFT诊断，病因和相关分子机制。

1. Introduction

Solitary fibrous tumour (SFT) is a ubiquitous fibroblastic mesenchymal tumour, which has the potential to affect any region of the body. It was first described in the pleura by Klemperer and Rebin in 1931, and later in 1942, these tumours were also observed in multiple sites [1,2]。大多数sft是无痛的,目前的定义boundary, and slow growing. Malignant tumours often show local infiltration and their diameter ranges between 1 and 30 cm. The sections of tumours have been frequently observed having a whitish and firm appearance with multiple nodules. Malignant tumours are characterized by aggressiveness with haemorrhagic necrosis and cystic degeneration [3,4]。sft形态多样化的特点by an alternate distribution of hypocellular and hypercellular areas, and haphazard growth pattern of spindle cells mixed with fibrous bundles and haemangiopericytoma-like vessels. According to the histomorphologic difference, SFTs can be classified into classical SFTs, giant cell SFTs, fat-forming SFTs, and malignant SFTs [5,6]。The histological features of SFTs are different from spindle cell lipoma, dermatofibrosarcoma protuberans, synovial sarcoma, and malignant peripheral nerve sheath tumours.

The genetic mechanism of SFT activity has been studied and has received extensive attention clinically. In recurrent SFTs, a fusion gene of NAB2-STAT6 was detected by comprehensive sequencing [7]。STAT6 is a newly discovered member of the transcription factor family that can combine with the target gene regulatory region. It functions doubly as an activator of signal transduction and transcription. NAB2-STAT6 gene fusion is an important driving gene of SFT. Overexpression of NAB2-STA6 can induce cell proliferation and EGR gene expression. Therefore, nuclear STAT6 immunoreactivity using a STAT6 antibody is a highly sensitive and helpful marker of SFTs. Additionally, Vivero et al. found that the GRIA2 gene was highly expressed in SFT, and GRIA2 tested positive in 80% of SFTs [8]。Typical SFTs show a patternless architecture characterized by a combination of hypocellular and hypercellular areas separated by thick bands of collagen and thin-walled branching haemangiopericytoma-like vessels. While most cases of SFTs are benign, their behaviour is unpredictable. About 10% SFT cases behave aggressively. Malignant SFTs show an increased rate of mitosis (>4 mitoses per 10 HPF), cytological atypia, tumour necrosis, and infiltrative margins.

Transcription factor E3 (TFE3), also known as weight chain immunoglobulin enhancer 3, belongs to the MITF (microphthalmia-associated transcription factor) family, which also comprises transcription factor EB (TFEB), transcription factor EC (TFEC), and MITF [9–11]。The MITF family is an important regulator of cell differentiation and development and is involved in the regulation of tumorigenesis [12]。TheTFE3gene is 14.78 kb long and is positioned in the short arm of X chromosome p11.22. The TFE3 protein is widely distributed in the human body and binds to the DNA in the form of a homologous dimer or a heterodimer to act as a transcription factor and play the regulatory role for multiple genes and signalling pathways [13]。Additionally, the TFE3 protein interacts with other regulators of transcription such as Smad3, E2F3, and LEF1 and plays a crucial role in the growth and expansion of cells and differentiation of osteoclasts and macrophages [14]。TFE3acts as an oncogene which is commonly rearranged in many tumour types, such as translocation of Xp11.2 leading to renal cell carcinoma, alveolar soft tissue sarcoma (ASPS), a subset of perivascular epithelioid cell tumours (PEComas), and partial epithelioid hemangiosarcoma [15,16]。It has been observed that increased TFE3 protein expression is not associated with gene translocation in many tumours such as hepatic angiomyolipoma, granulosa cell tumours, and solid pseudopapilloma of the pancreas [17,18]。

在SFT生物学阿一致的发现已使得NAB2-STAT6融合，从而使STAT6免疫组织学可靠用于检测融合基因，尽管在SFT恶性肿瘤的分子决定因素仍然被揭开。TFE3起着肿瘤发生的重要作用，虽然TFE3表达和SFTS之间的联系还没有评估。我们假设，TFE3可以是SFT的有用的诊断标记物，因此，试图评估在通过免疫组织化学分析50个SFTS TFE3表达;比较了这些表达模式到那些其它肿瘤类型的评估TFE3标记为SFTS的特异性;并评价TFE3与性别，肿瘤大小，有丝分裂速率比分，和SFT患者的预后的关联。

2. Materials and Methods

2.1. Patient Samples

A total of 50 surgically resected SFT specimens were acquired from the Pathology Department of the Ruijin Hospital in Shanghai, China. Samples were collected from August 2014 to May 2018. To assess the specificity of TFE3 to SFTs, we also carried out the tests on samples of malignant peripheral nerve sheath tumour, synovial sarcoma, dedifferentiated liposarcoma, spindle cell lipoma, and dermatofibrosarcoma protuberans. All specimens were fixed with 10% formaldehyde and embedded in paraffin. The cut sections (4 μm thick) were then stained with haematoxylin and eosin.

2.2. Immunohistochemical Staining and Evaluation

甲Dako公司OMNIS自动染色平台被用于整个组织切片的免疫组织化学染色（4- μm thick) embedded in paraffin and formalin-fixed. For details regarding the antibodies used in this study, see Table1。The antibodies were optimized using Ventana DAB detection kit (Ventana Medical Systems), and standard quality control procedures were carried out.

The immunohistochemical staining of TFE3 expressions was quantitatively scored on a scale of 0 to 3+ depending on the extent and the intensity of staining. The sample scored 0 if it did not stain at all; 1, if it stained weakly (light brown); 2, if it stained moderately intense (brown); and 3 in case of high intensity (dark brown). The percentage of TFE3-positive nuclei was scored as follows: 3 (>70%), 2 (40-70%), 1 (10-40%), and 0 (<10%). A histologic score was then generated by multiplying these two scores together, and the final positivity scores were assigned based on this histological score as follows: 3+ (a score of 9), 2+ (a score of 4 or 6), 1+ (a score of 2 or 3), and negative (a score of 0 or 1).

2.3. Fluorescence In Situ Hybridization (FISH) Assay

For the FISH assay, a Zytolight SPEC TFE3 Dual colour break-apart probe was used on 4 μm thick formalin-fixed and paraffin-embedded tissue sections. The signals of FISH were evaluated using a microscope Olympus BX51TRF (Olympus, Japan) by applying a triple-pass filter (DAPI/Green/Orange; Vysis). Signals were deemed split when the distance between red and green signals was ≥2 signal diameters. The TFE3 cases were FISH positive when the tumour samples contained more than 15% split signals [19]。

2.4. Statistical Analyses

The TFE3 expression was correlated with patient age and tumour size using the unpaired -test. Likewise, the expression of TFE3 was related to gender and mitotic rate score using the Fisher exact test. The event-free survival was estimated using the Kaplan-Meier method. Avalue < 0.05 was statistically significant.

3. Results

3.1. Clinicopathological Findings

We analysed a total of 50 SFT cases and 50 other lesion types as controls. A summary of the clinicopathological features is presented in Table2。Among the 50 SFT patients, 23 (46%) were male and 27 (54%) were female; their ages are in the range of 18-82 years (mean age: 52.08 years). When the tumour localization was assessed, they occurred in the retroperitoneum ( ),pelvic cavity subperitoneal tissue ( ),pleura ( ),lung ( ),胰腺（ ),kidney ( ),腮腺（ ),limbs ( ),buttocks ( ),central nervous system ( ),intestinal wall ( ),groin ( ),and bladder ( ).The dedifferentiated liposarcoma was found in the retroperitoneum, and the synovial sarcoma occurred mainly in the limbs.

The diameters of the largest and the smallest tumours were 19 cm and 1 cm, respectively. On sectioning, most SFTs exhibited a multinodular, whitish, and firm appearance. A further morphologic examination confirmed the diagnosis of all SFT cases. Histologically, 26 cases were of classic SFTs. The tumours of SFT present as a well-circumscribed but nonencapsulated mass, and there were dense and sparse areas with no special regularity in the cellular arrangement. At high magnification, spindle, oval, and round cells with less cytoplasm were observed. The chromatin was homogeneous, the nucleolus was not obvious, the atypia was not obvious, and there was no pathological mitotic image. The lesion presented a pattern mainly of spindle cells in low-to-moderate cellularity scattered within a prominent matrix made of collagen. A total of 10 cases were determined as cellular SFT, whose predominant histologic pattern was of ovoid-to-spindled cells in a densely cellular proliferation arrayed in a haphazard pattern, and contained in a less prominent stroma. Three cases were of fat-forming SFTs; their predominant histologic pattern was a variably prominent adipocytic component; one case was of giant cell SFT with pseudovascular or sinusoidal lacunae and multinucleated giant cells; 10 cases showed enhanced mitotic activity (>4/10 HPF) with or without spontaneous coagulative necrosis and were diagnosed as malignant SFTs (Figure1). Table2presents the clinicopathologic features in detail.

3.2. Immunohistochemical Findings

We conducted immunohistochemical staining for TFE3 in all 50 SFTs and observed malignant peripheral neurilemmoma ( ),synovial sarcoma ( ),梭形细胞脂肪瘤（ ),dermatofibrosarcoma protuberans ( ),and dedifferentiated liposarcoma ( ).The results are summarized in Table3。在所有50个SFT样品，STAT6呈阳性在所有SFT样本的案例。44（88％）为TFE3染色呈阳性（图2). TFE3 nuclear staining was strongly positive (3+) in 36 (72%) cases, moderately positive (2+) in 4 (8%) cases, and weakly positive (1+) in 3 (6%) cases, and 6 (12%) cases were completely TFE3 negative.

间恶性外周神经鞘肿瘤的情况下（ ),synovial sarcoma ( ),梭形细胞脂肪瘤（ ),dermatofibrosarcoma protuberans ( ),and dedifferentiated liposarcoma ( )samples were used as controls. The cases of malignant peripheral nerve sheath tumour we used as controls were S-100 and Sox-10 positive, while STAT6 was negative. CD34 and STAT6 were all negative in cases of synovial sarcoma. Dermatofibrosarcoma protuberans were CD34 diffusely positive and STAT6 negative. MDM2 and CDK4 were both positive in dedifferentiated liposarcoma cases used as controls (Figure3).

All examined cases of malignant peripheral nerve sheath tumour, synovial sarcoma, spindle cell lipoma, and dermatofibrosarcoma protuberans were TFE3 negative (Figure4). Two cases ( )of dedifferentiated liposarcoma were moderately positive for nuclear TFE3 (2+).

3.3. FISH Analysis

We next selected SFT samples ( )that had shown a strong nuclear TFE3 expression previously in the IHC analysis, to conduct FISH. Using a break-apart FISH assay, we observed a combination of signals indicating a lack of split signals in all the cases, indicating a lack of theTFE3gene rearrangement (Figure5).

3.4. Association of TFE3 Expression, Clinically Pathologic Characters, and the Outcomes

The TFE3 expression in SFTs did not correlate with clinicopathologic characteristics and outcome. There was no association of TFE3 with gender ( ),tumour size ( ),and age ( ).有丝分裂速度分离的情况下在两个组（≥4和<4），TFE3表达与有丝分裂速度相关联（ )(Table4). On analysing event-free survival using the Kaplan-Meier analysis, the patients positive for TFE3 expression did not have a significantly poor event-free survival than the cases with no expression ( ).During the follow-up, six of 44 TFE3-positive SFT patients relapsed and three patients died. No recurrence or death occurred in six SFT patients who tested negative for TFE3.

4. Discussion

SFT is a ubiquitous mesenchymal tumour of the fibroblastic type with a prominent haemangiopericytoma-like branching vascular pattern which often occurs in middle-aged adults and affects females and males equally. SFT shows a distinctive combination of ovoid- to spindle-shaped cells, irregular growth pattern, marked stromal collagen, and thin-walled branching haemangiopericytoma-like vessels. Nevertheless, it is often difficult to diagnose SFT and to distinguish it from other tumours of soft tissues owing to the wide histological variability, such as spindle cell lipoma, synovial sarcoma, the malignant peripheral tumour of the nerve sheath, dermatofibrosarcoma protuberans, and dedifferentiated liposarcoma. SFT and its differential diagnosis must be distinct for proper prognosis and treatment.

STAT6 and CD34 expressions were detected in SFT. There was no overexpression of p53 in SFT. The morphological characteristics between SFT and other mesenchymal spindle cell tumours are similar, such as malignant peripheral nerve sheath tumour, synovial sarcoma, spindle cell lipoma, dermatofibrosarcoma protuberans, and dedifferentiated liposarcoma. These spindle cell tumours need to be differentiated from SFT by immunohistochemical markers. Malignant peripheral nerve sheath tumours are often S-100 and Sox-10 positive. While Bcl-2 is negative, CD34 and STAT6 are negative in synovial sarcoma and can thus aid in differentiating from SFT. Dermatofibrosarcoma protuberans are often CD34 diffuse positive and STAT6 negative. Likewise, MDM2 and CDK4 are both positive in dedifferentiated liposarcoma that can thus be distinguished from SFT.

Immunohistochemical markers are vital in SFT diagnosis. While more than 90% of SFTs are CD34 positive [20),它不是具体的,因为它共享的表达sion in many spindle cell tumours. For instance, CD34 is diffuse positive in dermatofibrosarcoma protuberans. TFE3 is a useful marker for distinguishing SFT from most mimics. Particularly among other CD34 positive tumours, STAT6 is a useful SFT diagnostic marker due to the NAB2-STAT6 fusion in SFTs [21] and some other soft tissue tumours, such as dedifferentiated liposarcoma express STAT6. Gene expression studies in SFTs revealed 93% of SFTs to be positive for GRIA2 while 75% DFSP was positive for GRIA2 [8]。Thus, it is difficult to identify SFT and DFSP through GRIA2.

We detected TFE3 translocation, through FISH assay, in 10 TFE3 strongly positive SFT cases. Two samples displayed weak signals for TFE3 in dedifferentiated liposarcoma among control tumours, and 88% of SFT samples showed a strong presence of TFE3 indicating that TFE3 can act as a potential marker for the diagnosis of SFT.

TFE3 is immunologically highly specific and sensitive. Diffuse and strong TFE3 staining always correlates with translocation status. The fusion or amplification ofTFE3has been identified with molecular events such as perivascular epithelioid cell tumours (PEComas) and renal cell carcinoma associated with Xp11.2 translocation [22–24]。为了评估是否TFE3在SFT强表达通过易位引起的，我们检测TFE3易位，通过FISH测定，在10 TFE3强阳性SFT例。此外，结果表明，SFT核TFE3免疫组化染色和TFE3易位之间不存在任何关系。结果表明，虽然TFE3在88％SFC样品中过表达，这增加的表达背后的机制尚未被揭开。TFE3改变可能不会在软组织的主要分子事件驱动肿瘤发生。有研究发现，PI3K-AKT-mTORC1信号传导途径中，Wnt /β-catenin信号通路和TGF-β信号通路主要与TFE3调节有关。TFE3由营养状况调节。在饱腹感，mTORC1的依赖的磷酸化诱导TFE3留在细胞质中，而饥饿期间，TFE3易位至与溶酶体和自噬[相关联的若干基因的细胞核并诱导转录25]。TFE3激活的Wnt /β-连环蛋白信号，形成所述MITF家族的成员和Wnt信号传导途径[之间的正反馈环26,27]。Brady et al. observed that when DNA damage occurs, p53 activates TFE3 by inhibiting mTORC1 activity. This p53-dependent TFEB and TFE3 activation further enhance the p53 signal through feedback and the negative feedback mechanism, resulting in the increase of p53 stability and protein level, leading to the increased expression of many transcription factors involved in DNA damage response and repair [28]。However, the mechanism of TFE3 overexpression in SFT is still unclear as there was no rearrangement of this gene shown by FISH. We speculate that the expression of TFE3 in SFT may be associated with autophagy and the PI3K-AKT-mTORC1 signalling pathway. However, the underlying mechanism needs more in-depth research.

The biological behaviour of SFT is still uncertain. They can turn into malignant tumours and recur at a rate of about 10%. They can also invade surrounding tissues and organs, such as the vertebral body, and compress the spinal cord, which indicates that they are low-grade or potentially malignant tumours. Malignant SFTs account for about 20% of tumours. They may be primary or benign in nature and their biological behaviour depends on the size and growth pattern of tumours. Malignant SFTs are usually hypercellular lesions, showing increased mitosis (>4 mitosis events per 10 HPF), variable cytological atypia, tumour necrosis, and/or infiltrative margins [4,29]。Our results indicate the nonsignificance of TFE3 expression with respect to the biological behaviour of SFT. All the six TFE3-negative cases in SFTs did not have a relapse, and all the patients were in good condition on follow-up in this study. Our results also show that TFE3 expression has no relationship with the age, tumour size, gender, and mitosis events of SFT patients.

5. Conclusions

In SFT, TFE3 immunohistochemical staining is a useful diagnostic marker and can be combined with STAT6 for better diagnosis, as very few soft tissue tumours are TFE3 positive. We also verified that the increase in TFE3 expression was unrelated to Xp11 gene translocation events. Our findings offer novel insights into the diagnosis, aetiology, and molecular mechanisms of SFT.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

作者的贡献

Luting Zhou and Anran Wang contributed equally to this work.

Acknowledgments

This work is supported by the Shanghai Science and Technology Commission (17ZR1417500).

References

1. C. F. Branch, “Primary neoplasm of heart valve,”The American Journal of Pathology, vol. 7, no. 2, pp. 157–160.1, 1931.View at:Google Scholar
2. A. P. Stout and M. R. Murray, “Hemangiopericytoma: a vascular tumor featuring Zimmermann's pericytes,”Annals of Surgery, vol. 116, no. 1, pp. 26–33, 1942.View at:Publisher Site|Google Scholar
3. M. Fukunaga, H. Naganuma, T. Nikaido, T. Harada, and S. Ushigome, “Extrapleural solitary fibrous tumor: a report of seven cases,”Modern Pathology, vol. 10, no. 5, pp. 443–450, 1997.View at:Google Scholar
4. M. Fukunaga, H. Naganuma, S. Ushigome, Y. Endo, and E. Ishikawa, “Malignant solitary fibrous tumour of the peritoneum,”Histopathology, vol. 28, no. 5, pp. 463–466, 2003.View at:Publisher Site|Google Scholar
5. A. V. Vallat-Decouvelaere, S. M. Dry, and C. D. M. Fletcher, “Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors,”The American Journal of Surgical Pathology, vol. 22, no. 12, pp. 1501–1511, 1998.View at:Publisher Site|Google Scholar
6. J. M. Mosquera and C. D. M. Fletcher, “Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component - is this dedifferentiated SFT?”The American Journal of Surgical Pathology, vol. 33, no. 9, pp. 1314–1321, 2009.View at:Publisher Site|Google Scholar
7. D. R. Robinson, Y. M. Wu, S. Kalyana-Sundaram et al., “Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing,”Nature Genetics, vol. 45, no. 2, pp. 180–185, 2013.View at:Publisher Site|Google Scholar
8. M. Vivero，L. A.道尔，C. D. M.弗莱彻，F. Mertens的，和J. L. Hornick，“GRIA图2是用于通过基因表达谱鉴定孤立性纤维性肿瘤的新型诊断标记物，”Histopathology, vol. 65, no. 1, pp. 71–80, 2014.View at:Publisher Site|Google Scholar
9. G. Napolitano and A. Ballabio, “TFEB at a glance,”Journal of Cell Science, vol. 129, no. 13, pp. 2475–2481, 2016.View at:Publisher Site|Google Scholar
10. j·a·玛蒂娜·h·迪亚布,l .李树et al .,“nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris,”Science Signaling, vol. 7, no. 309, p. ra9, 2014.View at:Publisher Site|Google Scholar
11. W. Chantarawong, K. Takeda, W. Sangartit, M. Yoshizawa, K. Pradermwong, and S. Shibahara, “Microphthalmia-associated transcription factor as the molecular target of cadmium toxicity in human melanocytes,”Biochemical and Biophysical Research Communications, vol. 454, no. 4, pp. 594–599, 2014.View at:Publisher Site|Google Scholar
12. E. Steingrimsson, L. Tessarollo, B. Pathak et al., “Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development,”Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 7, pp. 4477–4482, 2002.View at:Publisher Site|Google Scholar
13. E.Steingrímsson，N. G.科普兰和N. A.詹金斯，“黑素细胞和Microphthalmiatranscription factor network,”Annual Review of Genetics, vol. 38, no. 1, pp. 365–411, 2004.View at:Publisher Site|Google Scholar
14. R. Ramphal, A. Pappo, M. Zielenska, R. Grant, and B. Y. Ngan, “Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family,”American Journal of Clinical Pathology, vol. 126, no. 3, pp. 349–364, 2006.View at:Publisher Site|Google Scholar
15. J. C.霍奇，K. E.皮尔斯，X.王，A. E. Wiktor的，A. M.奥利维拉和P. T. Greipp，“分子用于细胞遗传学分析TFE3rearrangement in Xp11. 2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases,”Modern Pathology, vol. 27, no. 1, pp. 113–127, 2014.View at:Publisher Site|Google Scholar
16. R. Haq and D. E. Fisher, “Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer,”Journal of Clinical Oncology, vol. 29, no. 25, pp. 3474–3482, 2011.View at:Publisher Site|Google Scholar
17. N. Jimbo, T. Nishigami, M. Noguchi et al., “Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations,”Human Pathology, vol. 61, pp. 41–48, 2017.View at:Publisher Site|Google Scholar
18. J. K. Schoolmeester and R. R. Lastra, “Granular cell tumors overexpress TFE3 without corollary gene rearrangement,”Human Pathology, vol. 46, no. 8, pp. 1242-1243, 2015.View at:Publisher Site|Google Scholar
19. H. J. Lee, D. H. Shin, G. Y. Noh et al., “Combination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methods,”Oncotarget, vol. 8, no. 19, pp. 30756–30765, 2017.View at:Publisher Site|Google Scholar
20. W. H. Westra, W. L. Gerald, and J. Rosai, “Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit,”The American Journal of Surgical Pathology, vol. 18, no. 10, pp. 992–998, 1994.View at:Publisher Site|Google Scholar
21. L. A. Doyle, M. Vivero, C. D. Fletcher, F. Mertens, and J. L. Hornick, “Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics,”Modern Pathology, vol. 27, no. 3, pp. 390–395, 2014.View at:Publisher Site|Google Scholar
22. H. J. Lee, D. H. Shin, S. Y. Kim et al., “TFE3translocation and protein expression in renal cell carcinoma are correlated with poor prognosis,”Histopathology, vol. 73, no. 5, pp. 758–766, 2018.View at:Publisher Site|Google Scholar
23. N. P. Agaram, Y. S. Sung, L. Zhang et al., “Dichotomy of genetic abnormalities in PEComas with therapeutic implications,”The American Journal of Surgical Pathology, vol. 39, no. 6, pp. 813–825, 2015.View at:Publisher Site|Google Scholar
24. P. Argani, S. Aulmann, P. B. Illei et al., “A distinctive subset of PEComas harbors TFE3 gene fusions,”The American Journal of Surgical Pathology, vol. 34, no. 10, pp. 1395–1406, 2010.View at:Publisher Site|Google Scholar
25. R. Willett, J. A. Martina, J. P. Zewe, R. Wills, G. R. V. Hammond, and R. Puertollano, “TFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomes,”Nature Communications, vol. 8, no. 1, article 1580, 2017.View at:Publisher Site|Google Scholar
26. D. Ploper and E. M. De Robertis, “The MITF family of transcription factors: role in endolysosomal biogenesis, Wnt signaling, and oncogenesis,”Pharmacological Research, vol. 99, pp. 36–43, 2015.View at:Publisher Site|Google Scholar
27. D. Ploper, V. F. Taelman, L. Robert et al., “MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells,”Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 5, pp. E420–E429, 2015.View at:Publisher Site|Google Scholar
28. e .宋o·a·布雷迪j·a·玛蒂娜·m·Pirooznia, I. Tunc, and R. Puertollano, “The transcription factors TFE3 and TFEB amplify p53 dependent transcriptional programs in response to DNA damage,”eLife, vol. 7, article e40856, 2018.View at:Publisher Site|Google Scholar
29. T. Hasegawa, Y. Matsuno, T. Shimoda, F. Hasegawa, T. Sano, and S. Hirohashi, “Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior,”Human Pathology, vol. 30, no. 12, pp. 1464–1473, 1999.View at:Publisher Site|Google Scholar

Copyright

Copyright © 2020 Luting Zhou et al. This is an open access article distributed under theCreative Commons Attribution License，其允许在任何介质无限制地使用，分发和再现时，所提供的原始工作正确的引用。